Rankings
▼
Calendar
TVTX Q1 2021 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TVTX
Travere Therapeutics, Inc.
$3B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$47M
-0.8% YoY
Gross Profit
$46M
96.5% margin
Operating Income
-$48M
-100.3% margin
Net Income
-$54M
-113.6% margin
EPS (Diluted)
$-0.96
QoQ Revenue Growth
-7.0%
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$36M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$764M
Total Liabilities
$401M
Stockholders' Equity
$363M
Cash & Equivalents
$148M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$47M
$48M
-0.8%
Gross Profit
$46M
$46M
-1.4%
Operating Income
-$48M
-$15M
-215.6%
Net Income
-$54M
$808,000
-6766.7%
Revenue Segments
Tiopronin Products
$25M
54%
Bile Acid Products
$22M
46%
← FY 2021
All Quarters
Q2 2021 →